Kapp D S, Brown A N, Cox W, Cox R S
Department of Radiation Oncology, Stanford University School of Medicine, CA 94305.
Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):331-44. doi: 10.1016/0360-3016(93)90245-q.
To evaluate the influence of pretreatment tumor temperatures and the temperature differential between treatment and pretreatment temperatures on local tumor control in patients who underwent combined radiation therapy and hyperthermia.
Mapped intratumoral temperatures were measured immediately prior to and during hyperthermia in 138 hyperthermia fields among 59 patients with nodular (60 fields) or diffuse (78 fields) superficially-located tumors. In the nodular subgroup there were 40 fields with adenocarcinomas (31 breast, two prostate, seven other primary sites), six melanomas, nine squamous cell carcinomas, and five other histologies. The fields with diffuse tumor involvement consisted of 77 adenocarcinomas (67 breast, 10 other) and one melanoma. The maximum, minimum, and average temperatures were determined for both the pretreatment (pTmax, pTmin, pTave) and treatment (Tmax, Tmin, Tave) distributions and the differences, Dm = Tmin-pTmax, and Da = Tmin-pTave, computed. These quantities were averaged over treatments to produce the corresponding mean quantities for each hyperthermia field. Univariate and multivariate analyses were performed to determine treatment and pretreatment parameters which best correlated with the duration of local control.
Pretreatment tumor temperatures were significantly lower than the oral temperatures with mean pTmax, mean pTmin, and mean pTave of 36.2 degrees C, 34.2 degrees C, and 35.4 degrees C, respectively. For the adenocarcinomas with diffuse involvement within the hyperthermia field, the covariates best correlating with local control duration on univariate analysis were concurrent radiation dose (p = 0.0026), Dm (p = 0.009), pTmax (p = 0.012) and Da (p = 0.036). Lower pTmax and larger Dm and Da were predictive for longer local control. In multivariate analyses, all thermal parameters lost power, however, the best model included Dm which was significant at the p = 0.040 level. For the nodular subgroup, nonthermal parameters and dichotomized thermal parameters were of prognostic significance for local control.
For fields diffusely involved with adenocarcinoma significant correlations with duration of local control have been demonstrated both for a) low pretreatment temperatures and b) large differentials between treatment and pretreatment intratumoral temperatures. These correlations were also found in a dichotomized description for fields with nodular tumors. The results support the concept that pretreatment hypothermic conditions can lead to an increase in thermal sensitization and may help explain the excellent clinical results noted in the treatment of superficial tumors with radiation and hyperthermia. Further exploitation of this approach by planned cooling of superficially-located recurrent tumors prior to hyperthermia treatment warrants investigation.
评估在接受放射治疗与热疗联合治疗的患者中,治疗前肿瘤温度以及治疗温度与治疗前温度之间的温差对局部肿瘤控制的影响。
对59例患有结节状(60个区域)或弥漫性(78个区域)浅表肿瘤的患者的138个热疗区域,在热疗前及热疗过程中测量瘤内温度。在结节状亚组中,有40个区域为腺癌(31个乳腺、2个前列腺、7个其他原发部位),6个黑色素瘤,9个鳞状细胞癌,以及5个其他组织学类型。弥漫性肿瘤累及的区域包括77个腺癌(67个乳腺、10个其他)和1个黑色素瘤。确定治疗前(pTmax、pTmin、pTave)和治疗(Tmax、Tmin、Tave)分布的最高、最低和平均温度,并计算差异值Dm = Tmin - pTmax和Da = Tmin - pTave。将这些量在各次治疗中进行平均,以得出每个热疗区域相应的平均量。进行单因素和多因素分析,以确定与局部控制持续时间最相关的治疗和治疗前参数。
治疗前肿瘤温度显著低于口腔温度,平均pTmax、平均pTmin和平均pTave分别为36.2℃、34.2℃和35.4℃。对于热疗区域内弥漫性累及的腺癌,单因素分析中与局部控制持续时间最相关的协变量为同期放射剂量(p = 0.0026)、Dm(p = 0.009)、pTmax(p = 0.012)和Da(p = 0.036)。较低的pTmax以及较大的Dm和Da预示着更长的局部控制时间。在多因素分析中,所有热参数的作用减弱,然而,最佳模型包括Dm,其在p = 0.040水平具有显著性。对于结节状亚组,非热参数和二分热参数对局部控制具有预后意义。
对于弥漫性累及腺癌的区域,已证实a)低治疗前温度和b)治疗与治疗前瘤内温度之间的大温差均与局部控制持续时间显著相关。在对结节状肿瘤区域的二分描述中也发现了这些相关性。结果支持这样的概念,即治疗前低温条件可导致热敏感性增加,并可能有助于解释在浅表肿瘤放射治疗与热疗联合治疗中所观察到的优异临床结果。在热疗治疗前对浅表复发性肿瘤进行计划性降温,进一步探索这种方法值得研究。